A Study to Identify and Characterize LAL-D Patients in High-risk Populations

NCT02345421 · clinicaltrials.gov ↗
TERMINATED
Status
640
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Alexion Pharmaceuticals, Inc.